Search

everythinglearnresearchcommunity

for

Search:↓

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Hair hormone levels can indicate stress after a medically indicated abortion.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Creating specific biological indicators is important for early detection and treatment of PCOS.

Adult offspring of sperm donation generally feel positive about their conception and view the donor as their biological father.

Hair follicles and urine cell pellets are promising for transcriptome studies.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Regulating keratinocyte growth in engineered skin can improve wound healing.

SUN11602 and ONO-1301 could help in skin healing and creating artificial skin.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

A mother's diet at conception can cause lasting genetic changes in her child.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Reporter characteristics affect detection of hair loss from cancer therapy.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Preoperative stress markers alone don't predict chronic post-surgical pain.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

A new method effectively predicts estrogen-related health effects for early screening.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.